A Placebo-Controlled, Randomized, Double-Blind Study of Adjunctive Bupropion Sustained Release in the Treatment of SSRI-Induced Sexual Dysfunction - Concepedia

Concepedia

Publication | Closed Access

A Placebo-Controlled, Randomized, Double-Blind Study of Adjunctive Bupropion Sustained Release in the Treatment of SSRI-Induced Sexual Dysfunction

74

Citations

0

References

2005

Year

Charles DeBattista, Brent Solvason, Jennifer Poirier, Ellen Kendrick, Emily Loraas

The Journal of Clinical Psychiatry

Abstract

A fixed dose of 150 mg/day of bupropion SR taken in the morning does not appear to be effective in the treatment of SSRI-induced sexual dysfunction. Additional trials will be required to define what role, if any, bupropion might have in the treatment of SSRI-induced sexual side effects.